I-5% ye-dicngofenac sodium umjovo wezilwane

Ukwakheka

I-ML ngayinye iqukethe i-diclofenac sodium 50mg

Izakhiwo:

I-DicLofenac sodium, sodium 2 - [(2,6-dichlororonyl) I-Amino] PhenyLacetate ingenye yezidakamizwa ezingezona ze-anti-infloidal I-DicLofenac sodium njengoba i-anti-inflammatory, imiphumela ye-analgesic ne-antipyretic kungenxa yokwehla kwe-Prostaglandin synthesis kusuka ku-arachidonic acid ngokuvinjwa kwe-cyclo-oxygenase. Umphumela wayo u-2 ~ 2 amahlandla amahlandla anamandla kune-Indomethacin kanye ne-26 ~ 50 izikhathi ezingama-50 zinamandla kune-acetylssalicylic acid. Ibonakala ngokusebenza kahle kwezidakamizwa, ukusabela okunzima okunamandla, imithamo emincane, kanye nokwehluka okuncane komuntu ngamunye.

Izinga lokubopha lesidakamizwa ku-plasma protein lingama-99.7%. I-Half-Life ingamahora ayi-1 kuye kwangama-2. Ngokwethamo elinconyiwe kanye nesikhathi sokuphumula, akukho ukunqwabelana. Lesi sidakamizwa sihlanjululwa yisibindi, futhi cishe ama-60% enani lokwelashwa lama-metabolites alikhishwa ezinsolweni, futhi ukukhishwa kwesidakamizwa sokuqala kungaphansi kwe-1%. Yonke eminye imithamo isesimweni se-metabolites, ifakwe emathunjini nge-bile, futhi isuliwe emigodini.

Izinkomba

Antipyretic anlogesics. I-Diclofenac sodium umjovo njenge-anti-inflammatory ne-analgesic, kukhonjisiwe ngokulawulwa kobuhlungu nokuvuvukala okuhambisana nokuphazamiseka kwamathambo ama-musclo-skele I-Arthritis, i-Osteoarthritis, i-Osteochondritis, i-Bursitis, i-tendanitis ne-myositis, i-acuumonia, i-mastitis ebukhali kanye ne-enteritis.

Iphinde isetshenziselwe ukulawulwa komkhuhlane ohambisana nokutheleleka noma ukuwohloka kwezicubu ezinhlotsheni zezilwane ezahlukahlukene.

Umthamo nokuphatha

Umjovo we-intramuscular:

umthamo owodwa, u-1.25mg ngesisindo somzimba we-1kg;

Izilwane eziqhubekayo zisetshenziswa izinsuku ezingama-1-3.

Izinyathelo zokuzivikela:Kufanele ifakwe kancane.

Ukubeka: Gcina endaweni epholile, eyomile futhi emnyama. Gcina ungafinyeleleki ezinganeni.

UHebei Veyong Pharmaceutical Co, Ltd, wasungulwa ngonyaka ka-2002, etholakala eShijiazhuang City, esifundeni saseHebei, eChina, eduze kwenhloko-dolobha eBeijing. Uyibhizinisi elikhulu lezidakamizwa eliqinisekisiwe le-GMP, nge-R & D, ukukhiqizwa kanye nokuthengiswa kwama-apis wezilwane, amalungiselelo, okuphakelayo okubekiwe kanye nokuphakelwa izengezo. Njengesikhungo sezobuchwepheshe sesifundazwe, uVeyong usungule uhlelo olusha lwe-R & D lwe-New Veterinary Drug, futhi yiwona we-technological annology ebhizinisini elisuselwa kubuchwepheshe, kukhona ochwepheshe bezobuchwepheshe abangama-65. UVeyong unezisekelo ezimbili zokukhiqiza: I-Shijuazhuang kanye ne-Ordos, lapho iShijuazhuange isiza ifaka indawo engu-78,706 m2, i-Oxytetracycline imigqa yokukhiqiza kubandakanya i-ivermectin, i-olytetracycline imigqa yokukhiqiza kubandakanya umjovo, i-bolus, ama-pesticides kanye amagciwane, amahlelo. UVeyong unikeza ama-API, amalungiselelo angaphezu kwe-100 anamalebula, kanye nensizakalo ye-OEM & ODM.

UVeyong unamathela ngokubaluleka okukhulu ekuphathweni kwe-EHS (imvelo, ezempilo kanye nokuphepha), futhi uthole izitifiketi ze-ISO14001 nezi- ohsas180000. UVeyong ubhalwe phansi kumabhizinisi wezimboni asafufusa izimboni esifundazweni saseHebei futhi angaqinisekisa ukunikezwa kwemikhiqizo okuqhubekayo.

UVeyong wasungula uhlelo oluphelele lokuphathwa kwekhwalithi, ethola isitifiketi se-ISO9001, isitifiketi se-China GMP, isitifiketi se-APHVMA GMP, isitifiketi se-Ethiopia GMP, isitifiketi se-Ivermectin CEP, futhi sadlula ukuhlolwa kwe-US FDA. UVeyong uneqembu eliqeqeshiwe lokurejista, ukuthengisa kanye nenkonzo yezobuchwepheshe, inkampani yethu ithole ukuthembela nokusekelwa okuvela kumakhasimende amaningi ngekhwalithi ephezulu yomkhiqizo, insizakalo ephezulu yokuthengisa kanye nokuthengisa okuthengiswayo, ukuphathwa okungathi sína. UVeyong wenze ukubambisana isikhathi eside ngamabhizinisi amaningi ezaziwayo ezingezemikhiqizo athunyelwe eYurophu, eSouth America, eMpumalanga Ephakathi, e-Eshiya, e-ESIA, amazwe angaphezu kwangu-60.